Acute kidney injury with sodium-glucose co-transporter-2 inhibitors across the cardiovascular and renal outcome trials: Foe or friend?
Main Authors: | Dimitrios Patoulias, Christodoulos Papadopoulos, Fotios Siskos, Michael Doumas |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Elsevier
2023-09-01
|
Series: | Nefrología |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0211699521002083 |
Similar Items
-
Acute kidney injury with sodium-glucose co-transporter-2 inhibitors across the cardiovascular and renal outcome trials: Foe or friend?
by: Dimitrios Patoulias, et al.
Published: (2023-09-01) -
Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study
by: Dimitrios Patoulias, et al.
Published: (2022-08-01) -
Renal Oxygen Demand and Nephron Function: Is Glucose a Friend or Foe?
by: Edoardo Gronda, et al.
Published: (2023-06-01) -
Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis?
by: Dimitrios Patoulias
Published: (2023-05-01) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
by: Bieke Soen, et al.
Published: (2018-06-01)